Roche Holding AG

Price Chart

Risk-Adjusted Performance

Also Listed On

Roche Holding AG (RO) Price Performance

Roche Holding AG (RO) trades on SIX Swiss Exchange in CHF. The company is classified in the Healthcare sector under the Drug Manufacturers - General industry. The stock currently trades at CHF331.80, down 0.12% from the previous close.

Over the past year, RO has traded between a low of CHF257.80 and a high of CHF382.20. The stock has gained 22.4% over this period. It is currently 13.1% below its 52-week high.

Roche Holding AG has a market capitalization of $258.10B, with a price-to-earnings ratio of 20.20 and a dividend yield of 2.98%.

About Roche Holding AG

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haematology, infectious diseases, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagnostic instruments; and digital health solutions. The company was founded in 1896 and is based in Basel, Switzerland.